Cargando…

Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment

Hepatitis B remains a significant global clinical problem, despite the implementation of safe and effective vaccination programs. The prevalence of hepatitis B virus (HBV) in patients with inflammatory bowel disease (IBD) largely follows the regional epidemiologic status. Serological screening with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Axiaris, Georgios, Zampeli, Evanthia, Michopoulos, Spyridon, Bamias, Giorgos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291024/ https://www.ncbi.nlm.nih.gov/pubmed/34321842 http://dx.doi.org/10.3748/wjg.v27.i25.3762

Ejemplares similares

Case Report: Malignant melanoma in a patient with Crohn’s disease treated with ustekinumab
por: Axiaris, Georgios, et al.
Publicado: (2023)

Retroflexion, a costless endoscopic maneuver, increases adenoma detection rate in the ascending colon
por: Michopoulos, Spyridon, et al.
Publicado: (2021)

Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Orfanoudaki, Eleni, et al.
Publicado: (2022)

The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study
por: Foteinogiannopoulou, Kalliopi, et al.
Publicado: (2021)

Correction to: The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study
por: Foteinogiannopoulou, Kalliopi, et al.
Publicado: (2021)

Systemic levels of human β-defensin 1 are elevated in patients with cirrhosis
por: Kaltsa, Garyfallia, et al.
Publicado: (2016)

Acute Pancreatitis Following Endoscopic Ampullary Biopsies without Attempted Cannulation of the Ampulla of Vater
por: Michopoulos, Spyridon, et al.
Publicado: (2016)

The Inflammatory Bowel Disease—Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version
por: Katsoula, Anastasia, et al.
Publicado: (2023)

Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
por: Zacharopoulou, Eirini, et al.
Publicado: (2022)

Predictors of colorectal cancer screening awareness among people working in a hospital environment
por: Michopoulos, Spyridon, et al.
Publicado: (2017)

Hepatitis E Virus Infection in Patients with Chronic Inflammatory Bowel Disease Treated with Immunosuppressive Therapy
por: Kounis, Ilias, et al.
Publicado: (2023)

Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease
por: Tran-Minh, My-Linh, et al.
Publicado: (2017)

Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort
por: Bamias, Giorgos, et al.
Publicado: (2021)

The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
por: Viazis, N., et al.
Publicado: (2023)

Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
por: Kostas, Athanasios, et al.
Publicado: (2017)

Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?
por: Dovrolis, Nikolas, et al.
Publicado: (2022)

Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment
por: Spera, Anna Maria
Publicado: (2022)

Serum Vitamins D, B9 and B12 in Greek Patients with Inflammatory Bowel Diseases
por: Gioxari, Aristea, et al.
Publicado: (2020)

Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease
por: Nguyen, Huyen-Tran, et al.
Publicado: (2017)

Prevalence of Fatigue and Unrecognized Depression in Patients with Inflammatory Bowel Disease in Remission under Immunosuppressants and Biologicals
por: Truyens, Marie, et al.
Publicado: (2021)

Effects of Anti-Inflammatory Treatment and Surgical Intervention on Endothelial Glycocalyx, Peripheral and Coronary Microcirculatory Function and Myocardial Deformation in Inflammatory Bowel Disease Patients: A Two-Arms Two-Stage Clinical Trial
por: Triantafyllou, Charilaos, et al.
Publicado: (2021)

Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
por: Yeo, Seong Jae, et al.
Publicado: (2018)

Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis
por: Giri, Suprabhat, et al.
Publicado: (2023)

Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy
por: Giagkou, Eftychia, et al.
Publicado: (2018)

Effects of Immunosuppressants on Immune Response to Vaccine in Inflammatory Bowel Disease
por: Cao, Yuan, et al.
Publicado: (2015)

IMPROVING THE VACCINATION RATES FOR IMMUNOSUPPRESSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Cheng, Tony, et al.
Publicado: (2022)

Enterocytozoon Bieneusi Infects Children With Inflammatory Bowel Disease Undergoing Immunosuppressive Treatment
por: Zajączkowska, Żaneta, et al.
Publicado: (2021)

Occult hepatitis B infection by a recombinant D/C virus in an immunosuppressed patient
por: Cruz, Gonçalo Pereira, et al.
Publicado: (2019)

The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn’s Disease With Poor Prognostic Factors: The MODIFY Study
por: Mantzaris, Gerassimos J, et al.
Publicado: (2021)

Immunosuppression in Patients with Chronic Hepatitis B
por: Seetharam, Anil, et al.
Publicado: (2014)

Risk of Uveitis in Patients With Inflammatory Bowel Disease on Immunosuppressive Drug Therapy
por: Barberio, Julie, et al.
Publicado: (2020)

Preserved in vitro immunoreactivity in children receiving long-term immunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis
por: Schleker, Teresa, et al.
Publicado: (2018)

Balkan Nephropathy: Evolution of Our Knowledge
por: Bamias, Giorgos, et al.
Publicado: (2008)

Roles of Hepatitis B Virus Mutations in the Viral Reactivation after Immunosuppression Therapies
por: Inoue, Jun, et al.
Publicado: (2019)

A multicenter, prospective, observational study of the long-term outcomes of Crohn’s disease patients under routine care management in Greece
por: Michopoulos, Spyridon, et al.
Publicado: (2018)

Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression—risks, screening, diagnosis and management
por: Fehily, Sasha R., et al.
Publicado: (2022)

Impact of immunosuppressants on SARS-CoV-2 infection in elderly patients with inflammatory bowel disease
por: Calafat, Margalida, et al.
Publicado: (2021)

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fbvphqtg4h4a5t6qk7or7tfa76